Dublin, March 27, 2023 (GLOBE NEWSWIRE) -- The "North America Kidney Transplant Market, Size, Forecast 2023-2027, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.
North America Kidney Transplant Market will increase by around US$ 14.76 Billion by 2027 US$ 11.36 Billion in 2022, at a CAGR of 5.37%
A kidney transplant is a surgical surgery that a healthy kidney is used to replace a damaged or sick kidney donated by another person. The goal of the transplant is to improve or restore the function of the recipient's kidneys, allowing them to live healthier lives with less dependence on dialysis. The success of a kidney transplant is dependent on various factors, including donor-recipient compatibility, good post-operative care, and the recipient's overall health.
In the United States and Canada, there is a large population of individuals with kidney disease, and a significant portion of these individuals require dialysis or a kidney transplant to manage their condition. A kidney transplant can offer these individuals a better quality of life, increased lifespan, and improved health outcomes compared to relying on dialysis alone.
Additionally, the availability of advanced medical technology and skilled medical professionals in North American countries make kidney transplantation a safe and effective option for eligible patients.
The number of kidney transplants in 2022 will be 30.67 thousand, rising to 39.44 thousand by 2027
Growing demand for kidney transplantation is also one of the key drivers driving expansion potential in the North American sector in the next years. A kidney transplant is reliant on a variety of variables and circumstances. These disorders include renal failure caused by several factors, such as acute dehydration and kidney damage.
The unexpected spike in COVID-19 cases is also expected to raise demand for PPE kits and gloves in North America. Governments from all across the world have taken several initiatives to combat the spread of the new coronavirus. However, the installation of the lockdown has caused global disruptions in the manufacture, distribution, and delivery of medical supplies.
Furthermore, health and clinic centers have declined drastically in recent years in order to preserve social distance. These issues will most likely restrict development opportunities in the kidney transplant industry in the next few years.
According to the (OPTN) Organ Procurement and Transplantation Network, 42,887 organ transplants will be done in the United States in 2022, a 3.7% increase over 2021.
In addition, for the first time, over 25,000 kidney transplants were done in the United States. The number of 25,498 represented a 3.4 percent increase over 2021. Furthermore, factors such as increased public awareness of organ donation, the development of healthcare infrastructure, and the implementation of favorable reimbursement policies will contribute to the market's growth.
However, problems such as high transplantation costs and lengthy wait times are important impediments to the expansion of the North American kidney transplant industry.
The United States captured the Highest Market Share
The North American Kidney Transplant Market is divided into; the United States, Mexico, and Canada. In the United States and Canada, there is a large population of individuals with kidney disease, and a significant portion of these individuals require dialysis or a kidney transplant to manage their condition. A kidney transplant can offer these individuals a better quality of life, increased lifespan, and improved health outcomes compared to relying on dialysis alone. Additionally, the availability of advanced medical technology and skilled medical professionals in North American countries make kidney transplantation a safe and effective option for eligible patients.
The Living Donor Transplant Market will rise in the Foreseeable Years
Based on types, the North American market is segmented into; deceased donor transplants and living donor transplants. The living donor transplant segment is forecasted to grow at a significant rate. As the living donor transplant takes place sooner, the kidney has fewer chances of rejection and lasts longer (15-20 years on average).
The Calcineurin Inhibitors Revenue will grow due to Advancement and Technology in the Healthcare Industry
The Drugs categorizes into; calcineurin inhibitors, antiproliferative agents, mTOR inhibitors, steroids, and antibodies. Calcineurin inhibitors are a class of immunosuppressive drugs used in the management of organ transplantation, including kidney transplantation, in North American countries.
These drugs help prevent the rejection of the transplanted organ by suppressing the immune system's response to the foreign tissue. The two most commonly used calcineurin inhibitors in North America are Cyclosporine and Tacrolimus. Both drugs are highly effective in preventing rejection, but they have different side-effect profiles and dosing requirements.
These drugs are administered orally or intravenously and are typically prescribed in combination with other immunosuppressive medications to provide a more complete and effective immunosuppression regimen for transplant patients. Patients on the waiting list vs. Liver organ transplants conducted in 2021 were 90,483 out of 25,498 transplants performed, According to the Organ Procurement and Transplantation Network Data.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 120 |
| Forecast Period | 2022 - 2027 |
| Estimated Market Value (USD) in 2022 | $11.36 Billion |
| Forecasted Market Value (USD) by 2027 | $14.76 Billion |
| Compound Annual Growth Rate | 5.3% |
| Regions Covered | North America |
Company Analysis
- Sanofi
- Pfizer, Inc.
- Novartis AG.
- B.Braun Melsungen AG
- Fresenius Medical Care
- Medtronic Plc
- TransMedics GroupInc
- Astellas Pharma Inc
Key Topics Covered:
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. North America Kidney Transplant Number and Market
5.1 Kidney Transplant Number
5.2 Kidney Transplant Market
6. Share Analysis - North America Kidney Transplant Market
6.1 North America (United States, Mexico & Canada) - Kidney Transplant Number Share
6.2 North America (United States, Mexico & Canada) - Kidney Transplant Market Share
6.3 By Types Market Share
6.4 By Drugs Market Share
7. United States - Kidney Transplant Number and Market
7.1 United States - Kidney Transplant Number
7.2 United States - Kidney Transplant Market
8. Canada - Kidney Transplant Number and Market
8.1 Canada - Kidney Transplant Number
8.2 Canada - Kidney Transplant Market
9. Mexico - Kidney Transplant Number and Market
9.1 Mexico - Kidney Transplant Number
9.2 Mexico - Kidney Transplant Market
10. Types - Kidney Transplant Market
10.1 Deceased Donor Transplant
10.2 Living Donor Transplant
11. Drugs - Kidney Transplant Market
11.1 Calcineurin Inhibitors
11.2 Antiproliferative Agents
11.3 mTOR Inhibitor
11.4 Steroids
11.5 Antibodies
12. Company Analysis
12.1 Overview
12.2 Resent Development
12.3 Revenue
For more information about this report visit https://www.researchandmarkets.com/r/yuld6h
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
